Holista Colltech Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Holista Colltech Limited with three other
companies in this sector in AUSTRALIA :
Cellmid Limited
(2020
sales of 7.48 million Australian Dollars [US$5.70 million]
of which 79%
was Advangen Japan),
Medlab Clinical Ltd
(5.37 million Australian Dollars [US$4.09 million]
of which 67%
was Pharmaceutical Research), and
Starpharma Holdings Limited
(7.12 million Australian Dollars [US$5.42 million]
of which 100%
was Discovery, development & commercial of D).
Sales Analysis.
Holista Colltech Limited reported sales of A$7.13 million (US$5.43 million)
for the
year ending
December of 2020.
This
represents
a
decrease of 1.9%
versus 2019, when the company's sales were A$7.27 million.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Holista Colltech Limited had sales
of A$6.79 million.